VEENAT 400 Imatinib Mesylate Tablet For Clinical, Hospital, Personal

Description –  Imatinib is an oral targeted therapy medication used to treat cancer.  Imatinib Tablet is a class of medications called kinase inhibitors. It works  by blocking the actions of abnormal protein that signals cancer cells to multiply , this helps to stop the spread of cancer cells.

Imatinib inhibits tyrosine kinase specifically BCA-ABL, C-KIT, and PDGFRA

 Imatib 400 Tablet is an anti-cancer medication. A protein enzyme, bcr-abl tyrosine kinase, responsible for the growth of abnormal proliferation of cancer cells. This medicine inhibits the proliferation and induces apoptosis (planned cell death) in bcr-abl positive cells (cancer cells). This is how it works to stop or slow the spread of cancer.

Uses or Treatment-Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Imatib 400 Tablet is to be taken with food.

Dosage form -Tablets

 In Treatment of Cancer

In several types of cancers like blood cancers, gastrointestinal stromal tumours, skin cancer (dermatofibrosarcoma protuberans), and bone marrow condition (aggressive systemic mastocytosis), Imatib 400 Tablet targets the specific proteins that contribute to the growth and spread of cancer cells. By stopping these proteins, the medicine slows down or even stops the growth of cancer. This helps shrink tumours, slow down their growth, and make the patients feel better.

Imatib 400 Tablet is used to treat several types of cancers. It is most commonly prescribed to treat blood cancers (chronic myeloid leukaemia and acute lymphocytic leukaemia) and gastrointestinal stromal tumours. It works by targeting specific proteins that contribute to the growth and spread of cancer cells.

Imatib 400 Tablet is also used for treatment of a skin tumour called dermatofibrosarcoma protuberans and a type of bone marrow condition called aggressive systemic mastocytosis.